1. PI3K/Akt/mTOR
  2. mTOR

mTOR

mTOR (mammalian target of Rapamycin) is a protein that in humans is encoded by the mTOR gene. mTOR is a serine/threonine protein kinase that regulates cell growth, cell proliferation, cell motility, cell survival, protein synthesis, and transcription. mTOR belongs to the phosphatidylinositol 3-kinase-related kinase protein family. mTOR integrates the input from upstream pathways, including insulin, growth factors and amino acids. mTOR also senses cellular nutrient, oxygen, and energy levels. The mTOR pathway is dysregulated in human diseases, such as diabetes, obesity, depression, and certain cancers. Rapamycin inhibits mTOR by associating with its intracellular receptor FKBP12. The FKBP12-rapamycin complex binds directly to the FKBP12-Rapamycin Binding (FRB) domain of mTOR, inhibiting its activity.

mTOR Related Products (50):

Cat. No. Product Name Effect Purity
  • HY-10219
    Rapamycin Inhibitor
    Rapamycin is a specific mTOR inhibitor with IC50 of 0.1 nM.
  • HY-10218
    Everolimus Inhibitor
    Everolimus is a targeted, highly specific agent with an IC50 for binding to isolated FKBP-12, or FKBP-12 complexed to mTOR of 5 to 6 nM, and no significant activity against other protein kinases.
  • HY-50673
    BEZ235 Inhibitor
    BEZ235 is a dual pan-class I PI3K and mTOR kinase inhibitor with IC50 of 4 nM/5 nM/7 nM/75 nM, and 6 nM for p110α/γ/δ/β and mTOR (p70S6K), respectively.
  • HY-13328
    INK-128 Inhibitor
    INK-128 is a potent and selective mTOR inhibitor with IC50 of 1 nM, > 200-fold less potent to class I PI3K isoforms, superior in blocking mTORC1/2 and sensitive to pro-invasion genes.
  • HY-10422
    AZD-8055 Inhibitor
    AZD-8055 is a novel ATP-competitive inhibitor of mTOR kinase activity, with an IC50 of 0.8 nM.
  • HY-13003
    Torin 1 Inhibitor
    Torin 1 is a potent inhibitor of mTORC, with IC50 values of 2 nM and 10 nM against mTORC1 and mTORC2, respectively.
  • HY-15177
    PF-04691502 Inhibitor
    PF-04691502 is a potent and selective inhibitor of PI3K and mTOR kinases with antitumor activity. PF-04691502 inhibits human and mouse PI3Kα with Ki of 1.8 and 1.2 nM, respectively, human PI3K isoforms β, δ, and γ with Ki of 2.1, 1.6, and 1.9 nM, respectively, and human mTOR with Ki of 16 nM.
  • HY-13002
    Torin 2 Inhibitor
    Torin 2 is a mTOR inhibitor with EC50 of 0.25 nM, and exhibits 800-fold selectivity over PI3K (EC50: 200 nM).
  • HY-10474
    PP 242 Inhibitor
    PP 242 is the first selective and ATP competitive mTOR inhibitor with IC50 of 8 nM.
  • HY-15247
    AZD2014 Inhibitor
    AZD2014 is a small-molecule ATP competitive mTOR inhibitor with IC50 of 2.81 nM.
  • HY-50908
    Deforolimus Inhibitor
    Deforolimus(AP23573; MK-8669; Ridaforolimus) is a selective mTOR inhibitor with IC50 of 0.2 nM; while not classified as a prodrug, mTOR inhibition and FKBP12 binding is similar to rapamycin.
  • HY-10297
    GSK2126458 Inhibitor
    GSK2126458 is a highly selective and potent inhibitor of PI3K with Ki of 0.019 nM/0.13 nM/0.024 nM/0.06 nM and 0.18 nM/0.3 nM for p110α/β/δ/γ, mTORC1/2, respectively.
  • HY-50710
    KU-0063794 Inhibitor
    KU-0063794 is a potent and highly specific dual-mTOR inhibitor, with IC50 of appr 10 nM for mTORC1 and mTORC2 in cell-free assays, but has no effect on PI3Ks.
  • HY-10423
    OSI-027 Inhibitor
    OSI-027 is a selective and potent dual inhibitor of mTORC1 and mTORC2 with IC50 of 22 nM and 65 nM, and more than 100-fold selectivity observed for mTOR than PI3Kα, PI3Kβ, PI3Kγ or DNA-PK.
  • HY-15174
    BEZ235 Tosylate Inhibitor
    NVP-BEZ235 is a dual PI3K and mTOR kinase inhibitor with IC50 values of 4, 75, 7, 5 nM for PI3Kα, β, γ, δ, respectively.
  • HY-13246
    GDC-0980 Inhibitor
    GDC-0980 is a potent, class I PI3K inhibitor for PI3Kα/β/δ/γ with IC50 of 5 nM/27 nM/7 nM/14 nM in cell-free assays, respectively, and also a mTOR inhibitor with Ki of 17 nM in a cell-free assay, and highly selective versus other PIKK family kinases.
  • HY-10044
    WYE-125132 Inhibitor
    WYE-125132 is a highly potent, ATP-competitive and specific mTOR kinase inhibitor with an IC50 of 0.19 nM, highly selective for mTOR versus PI3Ks or PI3K-related kinases hSMG1 and ATR.
  • HY-15248
    GDC-0349 Inhibitor
    GDC-0349 is a potent and selective ATP-competitive inhibitor of mTOR with Ki of 3.8 nM; >700-fold selectivity over PI3Kα and other 266 kinases.
  • HY-11042
    GNE-477 Inhibitor
    GNE-477 is a potent and efficacious dual PI3K/mTOR inhibitor with IC50 of 4 nM for PI3Kα, Kiapp is 21 nM for mTOR.
  • HY-14581
    Palomid 529 Inhibitor
    Palomid 529 is a potent inhibitor of mTORC1 and mTORC2 complexes.